Carr-Purcell-Meiboom-Gill imaging of prostate cancer: quantitative T2 values for cancer discrimination

Magnetic Resonance Imaging

Volumn 27, Issue 4, 2009, Pages 497-502

  Roebuck, Joseph R ^a,b   Haker, Steven J ^a   Mitsouras, Dimitris ^a   Rybicki, Frank J ^a   Tempany, Clare M ^a   Mulkern, Robert V ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; DOCETAXEL; PROTON;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARR PURCELL MEIBOOM GILL IMAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; QUANTITATIVE ANALYSIS; TUMOR BIOPSY;

ADULT; AGED; ALGORITHMS; ARTIFICIAL INTELLIGENCE; DISCRIMINANT ANALYSIS; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; PATTERN RECOGNITION, AUTOMATED; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 63349095979     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2008.08.001     Document Type: Article

References (28)

1. American Cancer Society. Cancer facts and figures 2007 (2007). www.cancer.org
2. Presti Jr. J.C. Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy. Radiol Clin North Am 38 (2000) 49-58
3. Yu K.K., and Hricak H. Imaging prostate cancer. Radiol Clin North AM 38 (2000) 59-85
4. Szot Barnes A., Haker S.J., Mulkern R.V., So M., D'Amico A.V., and Tempany C.M. Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer. Urology 66 (2005) 1319.e13-1319.e15
5. Poissonnier L., Chapelon J.Y., Rouviere O., Curiel L., Bouvier R., Martin X., et al. Control of prostate cancer by transrectal HIFU in 227 patients. European Urology 51 (2007) 381-387
6. Jager G.J., Rijter E.T.G., van da Kaa C., de la Rosette J.J., Oosterhof G.O.N., Thornbury J.R., et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 166 (1996) 845-852
7. Heuck A., Scheidler J., Sommer B., Graser A., Muller-Lisse U.G., and Massmann J. MR imaging of prostate cancer. Radiologue 43 (2003) 464-473
8. White S., Hricak H., Forstner R., Kurhanewicz J., Vigneron D.B., Zaloudek C.J., et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195 (1995) 385-390
9. Scheidler J., Hricak H., Vigneron D.B., et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213 (1999) 473-480
10. Van der Graaf M., van den Boogert H.J., Jager G.J., Barentsz J.O., and Heerschap A. Human prostate: multisection proton MR spectroscopic imaging with a single spin-echo sequence-preliminary experience. Radiology 213 (1999) 919-925
11. Zakian K.L., Sircar K., Hricak H., Chen H.N., Shukla-Dave A., Eberhardt S., et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234 (2005) 804-814
12. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imag 16 (2002) 196-200
13. Hosseinzadeh K., and Schwarz S.D. Endo-rectal diffusion weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imag (2004) 654-661
14. Mulkern R.V., Szot Barnes A., Haker S.J., Rybicki F.J., Maier S.E., and Tempany C.M.C. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imag 24 (2006) 563-568
15. 2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189 (2007) 323-328
16. Shimofusa R., Fujimoto H., Akamata H., Motoori K., Yamamoto S., Ueda T., et al. Diffusion-weighted imaging of prostate cancer. J Compu Assist Tomogr 29 (2005) 149-153
17. 2-weighted imaging. Eur J Radiol 61 (2007) 297-302
18. 2-weighted MR imaging; a multi-channel statistical classifier. Med Phys 30 (2003) 2390-2398
19. 2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 46 (2001) 1054-1058
20. 2 mapping: application to the prostate. J Magn Reson Imag 6 (1996) 603-607
21. Engelbrecht M.R., Huisman H.J., Laheij R.J.F., Jager G.J., van Leenders G.J.L.H., Hulsbergen-Van De Kaa C.A., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229 (2003) 248-254
22. Noworolski S.M., Henry R.G., Vigneron D.B., and Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 53 (2005) 249-255
23. Melki P.S., Jolesz F.A., and Mulkern R.V. Partial RF echo planar imaging with the FAISE method: I. Experimental and theoretical assessment of artifact. Magn Reson Med 26 (1992) 328-341
24. Melki P.S., Jolesz F.A., and Mulkern R.V. Partial RF echo planar imaging with the FAISE method: II. Contrast equivalence with spin echo sequences. Magn Reson Med 26 (1992) 342-354
25. 2-relaxation decay of in vivo muscle. Magn Reson Med 46 (2001) 592-599
26. Constable R.T., and Gore J.C. The loss of small objects in variable TE imaging: implications for FSE, RARE, and EPI. Magn Reson Med 28 (1992) 9-24
27. 2 measurements, Letter to the Editor. Radiology 232 (2004) 624-625
28. 2 quantification for clinical applications. J Magn Reson Imag 2 (1992) 541-553